SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049173
Filing Date
2024-04-26
Accepted
2024-04-26 16:20:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A notice_card_2024_defa14a.htm DEFA14A 13185
2 GRAPHIC img14012171_0.jpg GRAPHIC 171636
3 GRAPHIC img14012171_1.jpg GRAPHIC 106347
  Complete submission text file 0000950170-24-049173.txt   397170
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33185 | Film No.: 24884083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)